Ownership history in UBS Group AG · 4 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in MOLECULIN BIOTECH INC (MBRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 5,863 | +1,898 | +47.9% | 0.00% | $19K | $3.31 |
| 2025 Q3 | REDUCED | 3,965 | -4,024 | -50.4% | 0.00% | $2K | $13.25 |
| 2025 Q2 | REDUCED | 7,989 | -950 | -10.6% | 0.00% | $2K | $7.55 |
| 2024 Q4 | INITIATED | 8,939 | — | — | 0.00% | $15K | $42.50 |
As of 2025 Q4 — sorted by position size